Products
Platform
Research
Market
Learn
Compare UTI Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 4.0 | 5.0 |
Min SIP Amount | ₹500 | ₹500 |
Expense Ratio | 2.25 | 1.93 |
NAV | ₹292.13 | ₹432.23 |
Fund Started | 01 Aug 2005 | 04 Jun 1999 |
Fund Size | ₹1146.13 Cr | ₹4026.55 Cr |
Exit Load | Exit load of 1% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
4.0
5.0
Min SIP Amount
₹500
₹500
Expense Ratio
2.25
1.93
NAV
₹292.13
₹432.23
Fund Started
01 Aug 2005
04 Jun 1999
Fund Size
₹1146.13 Cr
₹4026.55 Cr
Exit Load
Exit load of 1% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 6.61% | 8.32% |
3 Year | 25.81% | 26.95% |
5 Year | 18.52% | 20.27% |
1 Year
6.61%
8.32%
3 Year
25.81%
26.95%
5 Year
18.52%
20.27%
Holding Analysis
Equity | 97.66% | 97.60% |
Cash | 2.34% | 2.33% |
Equity
97.66%
97.60%
Cash
2.34%
2.33%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 9.84% |
Cipla Ltd. | 5.43% |
Ajanta Pharma Ltd. | 4.80% |
Lupin Ltd. | 4.29% |
Procter & Gamble Health Ltd. | 4.13% |
Dr. Reddy's Laboratories Ltd. | 3.99% |
Glenmark Pharmaceuticals Ltd. | 3.54% |
Fortis Healthcare Ltd. | 3.48% |
Apollo Hospitals Enterprise Ltd. | 3.47% |
Gland Pharma Ltd. | 3.01% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.44% |
Divi's Laboratories Ltd. | 7.21% |
Max Healthcare Institute Ltd. | 6.50% |
Cipla Ltd. | 4.63% |
Lonza Group Ag | 4.09% |
Lupin Ltd. | 4.02% |
Gland Pharma Ltd. | 3.59% |
Mankind Pharma Ltd. | 3.57% |
Acutaas Chemicals Ltd. | 3.30% |
Krishna Institute of Medical Sciences Ltd | 3.26% |
Fund Manager
Name | Kamal Gada | Tanmaya Desai |
Start Date | 02 May 2022 | 27 Jun 2011 |
Name
Kamal Gada
Tanmaya Desai
Start Date
02 May 2022
27 Jun 2011
About Fund
Description | The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 01 Aug 2005 | 04 Jun 1999 |
Description
The scheme seeks to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
01 Aug 2005
04 Jun 1999
